Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants?


Gosling, RD; Ghani, AC; Deen, JL; von Seidlein, L; Greenwood, BM; Chandramohan, D; (2008) Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? Malaria Journal, 7. ISSN 1475-2875 DOI: 10.1186/1475-2875-7-54

[img]
Preview
Text - Published Version
License:

Download (441kB) | Preview

Abstract

Background: Intermittent preventive (or presumptive) treatment of infants (IPTi), the administration of a curative anti-malarial dose to infants whether or not they are known to be infected, is being considered as a new strategy for malaria control. Five of the six trials using sulphadoxine-pyrimethamine (SP) for IPTi showed protective efficacies (PEs) against clinical malaria ranging from 20.1-33.3% whilst one, the Ifakara study, showed a protective efficacy of 58.6%. Materials and methods: The possible mechanisms that could explain the differences in the reported PE of IPTi were examined by comparing output from a mathematical model to data from the six published IPTi trials. Results: Under stable transmission, the PE of IPTi predicted by the model was comparable with the observed PEs in all but the Ifakara study (ratio of the mean predicted PE to that observed was 1.02, range 0.39-1.59). When a reduction in the incidence of infection during the study was included in the model, the predicted PE of IPTi increased and extended into the second year of life, as observed in the Ifakara study. Conclusion: A decrease in malaria transmission during the study period may explain part of the difference in observed PEs of IPTi between sites and the extended period of protection into the second year of life observed in the Ifakara study. This finding of continued benefit of interventions in settings of decreasing transmission may explain why rebound of clinical malaria was absent in the large scale trials of insecticide-treated bed nets.

Item Type: Article
Keywords: PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND TRIAL, SULFADOXINE-PYRIMETHAMINE, TANZANIAN INFANTS, ANTIMALARIAL TREATMENT, UNCOMPLICATED MALARIA, ROUTINE VACCINATIONS, FALCIPARUM-MALARIA, AMODIAQUINE, CHILDREN, Antimalarials, administration & dosage, Drug Combinations, Humans, Infant, Malaria, drug therapy, epidemiology, prevention & control, transmission, Models, Theoretical, Protective Agents, administration & dosage, Pyrimethamine, administration & dosage, Randomized Controlled Trials as Topic, Sulfadoxine, administration & dosage, Treatment Outcome
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Research Centre: Malaria Centre
Centre for Maternal, Reproductive and Child Health (MARCH)
PubMed ID: 18387180
Web of Science ID: 255281000001
URI: http://researchonline.lshtm.ac.uk/id/eprint/7568

Statistics


Download activity - last 12 months
Downloads since deposit
212Downloads
319Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item